Vaccines Europe makes the case for vaccine-specific HTA

Regulatory NewsRegulatory NewsBiologics/ biosimilars/ vaccinesChemistry, Manufacturing and Controls (CMC)Clinical TrialsEuropeRegulatory Intelligence/PolicyResearch, Design and Development